Pacific Biosciences of California PACB Payments to Acquire Investments
Payments to Acquire Investments at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's payments to acquire investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's payments to acquire investments?
- Pacific Biosciences of California (PACB) reported payments to acquire investments of $52.45M in Q1 2026.
- How has Pacific Biosciences of California's payments to acquire investments changed year-over-year?
- Pacific Biosciences of California's payments to acquire investments decreased by 15.2% year-over-year, from $61.82M to $52.45M.
- What is the long-term trend for Pacific Biosciences of California's payments to acquire investments?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's payments to acquire investments has grown at a -31.5% compound annual growth rate (CAGR), from $988.05M to $216.91M.